
BioXcel Therapeutics Inc (NASDAQ:BTAI) shares are trading higher. The AI biopharmaceutical company on Monday announced positive meeting comments from the U.S. Food and Drug Administration (FDA).
What Happened: BioXcel Therapeutics said the FDA provided positive pre-sNDA feedback that gives the company confidence that the planned sNDA (supplemental New Drug Application) regulatory package will be sufficient to support its sNDA submission.